引用本文
  •    [点击复制]
  •    [点击复制]
PDF HTML全文阅读
本文已被:浏览 332次   下载 36 本文二维码信息
码上扫一扫!
贝蒌散结舒乳汤治疗痰瘀互结型乳腺增生患者的效果及对血清雌二醇和泌乳素的影响
束艳,杨爱微,万健
0
南京中医药大学附属南京医院南京市第二医院南京 210003;上海市浦东新区人民医院上海 201299;上海中医药大学上海 201299
摘要:
目的:研究三苯氧胺联合贝蒌散结舒乳汤对痰瘀互结型乳腺增生患者血清雌二醇(E2)、泌乳素(PRL)、中医证候积分、乳腺肿块评分及VAS评分的影响。方法:选取我院2022年2月—2024年2月收治的133例痰瘀互结型乳腺增生患者,采用随机数字表法分为对照组(66例,采用三苯氧胺治疗)和观察组(67例,采用三苯氧胺+贝蒌散结舒乳汤治疗)。比较两组乳腺导管直径及腺体厚度,血清E2、PRL水平,中医证候积分,乳腺肿块评分及VAS评分。结果:观察组临床总有效率为97.01%,高于对照组的84.85%(χ2=4.519,P =0.046)。治疗后,观察组腺体厚度及乳腺导管最粗管径小于对照组(P <0.05)。观察组的中医证候积分改善情况显著优于对照组(P <0.05)。治疗后,观察组患者血清E2、PRL水平明显低于对照组,差异均有统计学意义(P <0.05);治疗后观察组肿块评分、VAS评分明显低于对照组,差异均有统计学意义(P <0.05)。结论:三苯氧胺联合贝蒌散结舒乳汤可有效治疗痰瘀互结型乳腺增生患者,改善患者腺体厚度及乳腺导管最粗管径,调节血清激素水平,改善中医证候积分及乳腺肿块评分,值得在临床推广应用。
关键词:  三苯氧胺  贝蒌散结舒乳汤  腺体厚度  乳腺导管  雌二醇  泌乳素
DOI:10.3969/j.issn.1007-6948.2026.01.011
投稿时间:2025-06-25
基金项目:浦东新区卫生健康委员会学科建设计划(PWZxq2022-13)
Effect of Beilou Sanjie Shuru decoction on patients with mammary gland hyperplasia of phlegm-stasis interaction type and its influence on serum estradiol and prolactin levels
SHU Yan,YANG Ai-wei,WAN Jian
Abstract:
Objective To investigate the effects of tamoxifen combined with Beilou Sanjie Shuru decoction on serum estradiol (E2), prolactin (PRL), TCM syndrome score, breast mass score and VAS score in patients with breast hyperplasia of phlegm and blood stasis intermingled type. Methods A total of 133 patients with breast hyperplasia of phlegm and blood stasis intermingled type admitted to hospital from February 2022 to February 2024 were selected and divided into control group (66 cases, treated with tamoxifen) and the observation group (67 cases, treated with tamoxifen combined with Beilou Sanjie Shuru decoction) according to the random number table method. The diameters of breast ducts and glandular thickness diameters, serum E2 and PRL levels, TCM syndrome scores, breast mass scores and VAS scores were compared between the two groups. Results The total clinical efficacy rate of the observation group was 97.01%, which was higher than that of the control group (84.85%) (χ2=4.519, P =0.046). After treatment, the glandular thickness and thickest diameter of the mammary duct in the observation group were lower than those in the control group (P < 0.05). The improvement effect of the TCM syndrome score in the observation group was significantly better than that in the control group (P <0.05). After treatment, the serum E2 and PRL levels in the observation group were significantly lower than those in the control group, and the differences were statistically significant (P <0.05). After treatment, the breast mass score and VAS score of the observation group were significantly lower than those of the control group, and the differences were statistically significant (P <0.05). Conclusion Tamoxifen combined with Beilou Sanjie Shuru decoction can effectively treat patients with breast hyperplasia of phlegm and blood stasis intermingled type, reduce the thickness of the gland and the thickest diameter of the breast duct, regulate serum hormone levels, and improve the TCM syndrome score and breast mass score. It is worthy of clinical application.
Key words:  Tamoxifen  Beilou Sanjie Shuru decoction  glandular thickness  breast duct  estradiol  prolactin

用微信扫一扫

用微信扫一扫